What does Laboratoires S.m.b. do?
LABORATOIRES S.M.B. specializes in the development and manufacturing of high-quality pharmaceutical products. The company focuses on innovative solutions in the fields of dermatology and other therapeutic areas. With a commitment to research and development, LABORATOIRES S.M.B. aims to enhance patient care through effective treatments.
- Sectors
- Forestry companies
- Activities
- Signals
-
ProfitableProfitable € 19.99M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 172.89MStrong equity provides a buffer against setbacks.
Low riskLow risk 66.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.94A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 25.44MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 32.38MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 112.46MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 12.8%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
112.46M
|
€
104.60M
|
€
96.23M
|
€
92.84M
|
|
|
€
32.38M
|
€
39.36M
|
€
28.59M
|
€
31.37M
|
|
|
€
19.99M
|
€
35.14M
|
€
34.49M
|
€
56.13M
|
|
|
€
172.89M
|
€
212.90M
|
€
205.63M
|
€
182.37M
|
|
|
66.11%
|
88.02%
|
94.93%
|
95.2%
|
|
|
€
85.16M
|
€
28.50M
|
€
10.49M
|
€
8.90M
|
|
|
€
167.85M
|
€
141.26M
|
€
100.65M
|
€
91.30M
|
|
|
37.70
|
37.90
|
38.20
|
40.00
|
Publications 42
All publications- Demissions, Nominations 18/04/2024
- Demissions, Nominations 03/05/2023
- Demissions, Nominations 12/02/2020
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 29/11/2019
- Objet - Capital, Actions 28/11/2019
News
Show all- Europe Daily News, 30 January 2026 Mayer Brown 8 months ago
- Chronic Obstructive Pulmonary Disease Drugs Market To Rise In The 7Mm By 2030, Analysis By Delveinsight PR Newswire 5 years ago
- Huons Claims Inhaled Asthma Drug Zephirus Effective Vs Covid-19 매일경제 5 years ago
- Huons, Smb Sign License Agreement For Zephirus koreabiomed.com 8 years ago
Frequently asked questions
Answers to the most common questions about Laboratoires S.m.b., based on official government data and the filed annual accounts.
What is the VAT number of Laboratoires S.m.b.?
The VAT number of Laboratoires S.m.b. is BE0418.956.361.
What is the official website of Laboratoires S.m.b.?
The official website of Laboratoires S.m.b. is http://www.smblab.be.
How many employees work at Laboratoires S.m.b.?
In 2025, Laboratoires S.m.b. employed 37.70 full-time equivalents (FTE).
When was Laboratoires S.m.b. established?
Laboratoires S.m.b. was founded in 29-11-1978.
What is the official address of Laboratoires S.m.b.?
The official address of Laboratoires S.m.b. is Herdersliedstraat 26-28 Sint-Jans-Molenbeek 1080.
What is the legal form of Laboratoires S.m.b.?
The juridical form of Laboratoires S.m.b. is Public limited company (NV/SA).
What is the annual revenue of Laboratoires S.m.b.?
The revenue of Laboratoires S.m.b. for the 2025 financial year was €112,458,586.
What does Laboratoires S.m.b. do?
LABORATOIRES S.M.B. specializes in the development and manufacturing of high-quality pharmaceutical products. The company focuses on innovative solutions in the fields of dermatology and other therapeutic areas. With a commitment to research and development, LABORATOIRES S.M.B. aims to enhance patient care through effective treatments.
Is Laboratoires S.m.b. a reliable company?
Laboratoires S.m.b. is a registered Rechtspersoon with company number 0418.956.361 and can be verified through the official CBE database.
What is the credit limit of Laboratoires S.m.b.?
The estimated credit limit of Laboratoires S.m.b. is €10,000,000.
Is Laboratoires S.m.b. still active?
Laboratoires S.m.b. currently has the status "Normal situation" and is active.